Gottlieb Embraces New Regulatory Approaches in Oncology, Cell Therapies and Across the Agency

Drug Industry Daily
A A
Commissioner Scott Gottlieb said there’s no better time for him to work at the FDA, with a slate of new agency authorities providing a “watershed opportunity” to shape the regulatory process.

To View This Article:

Login

Subscribe To Drug Industry Daily